Skip to main content
. 2016 May 18;17(5):751. doi: 10.3390/ijms17050751

Figure 4.

Figure 4

In the kidney of UUO mice mRNA expression mesenchymal marker fibroblast specific protein -1 (FSP-1) (A) and desmin (B) are reduced by 19,20-EDP treatment. 19,20-EDP treatment also reduced kidney expression of the mesenchymal marker α-smooth muscle action (α-SMA) (C); representative photomicrographs (200×) showing α-SMA-immunopositive areas (black arrows) in the kidney of different experimental groups (D). All data are expressed as Mean ± SEM, * p < 0.05 vs. Sham-Vehicle, # p < 0.05 vs. UUO-Vehicle, n = 6.